These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 18726578)

  • 1. Synthesis of toll-like receptor-2 targeting lipopeptides as self-adjuvanting vaccines.
    Chua BY; Zeng W; Jackson DC
    Methods Mol Biol; 2008; 494():247-61. PubMed ID: 18726578
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of lipopeptide-based immunocontraceptive vaccines containing different lipid groups.
    Chua BY; Zeng W; Lau YF; Jackson DC
    Vaccine; 2007 Jan; 25(1):92-101. PubMed ID: 17055123
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipopeptide epitopes extended by an Nepsilon-palmitoyl-lysine moiety increase uptake and maturation of dendritic cells through a Toll-like receptor-2 pathway and trigger a Th1-dependent protective immunity.
    Zhu X; Ramos TV; Gras-Masse H; Kaplan BE; BenMohamed L
    Eur J Immunol; 2004 Nov; 34(11):3102-14. PubMed ID: 15368273
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipid-core-peptide system for self-adjuvanting synthetic vaccine delivery.
    Skwarczynski M; Toth I
    Methods Mol Biol; 2011; 751():297-308. PubMed ID: 21674338
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A totally synthetic lipopeptide-based self-adjuvanting vaccine induces neutralizing antibodies against heat-stable enterotoxin from enterotoxigenic Escherichia coli.
    Zeng W; Azzopardi K; Hocking D; Wong CY; Robevska G; Tauschek M; Robins-Browne RM; Jackson DC
    Vaccine; 2012 Jul; 30(32):4800-6. PubMed ID: 22634295
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunostimulants and Toll-like receptor ligands obtained by screening combinatorial lipopeptide collections.
    Reutter F; Jung G; Baier W; Treyer B; Bessler WG; Wiesmüller KH
    J Pept Res; 2005 Mar; 65(3):375-83. PubMed ID: 15787968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Highly immunogenic and totally synthetic lipopeptides as self-adjuvanting immunocontraceptive vaccines.
    Zeng W; Ghosh S; Lau YF; Brown LE; Jackson DC
    J Immunol; 2002 Nov; 169(9):4905-12. PubMed ID: 12391202
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synthesis, Characterization and Immunological Evaluation of Self-Adjuvanting Group A Streptococcal Vaccine Candidates Bearing Various Lipidic Adjuvanting Moieties.
    Fagan V; Hussein WM; Su M; Giddam AK; Batzloff MR; Good MF; Toth I; Simerska P
    Chembiochem; 2017 Mar; 18(6):545-553. PubMed ID: 28075053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Method for the synthesis of highly pure vaccines using the lipid core peptide system.
    Moyle PM; Olive C; Good MF; Toth I
    J Pept Sci; 2006 Dec; 12(12):800-7. PubMed ID: 17131293
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Design of fully synthetic, self-adjuvanting vaccine incorporating the tumor-associated carbohydrate Tn antigen and lipoamino acid-based Toll-like receptor 2 ligand.
    Abdel-Aal AB; El-Naggar D; Zaman M; Batzloff M; Toth I
    J Med Chem; 2012 Aug; 55(15):6968-74. PubMed ID: 22800462
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chirality of TLR-2 ligand Pam3CysSK4 in fully synthetic peptide conjugates critically influences the induction of specific CD8+ T-cells.
    Khan S; Weterings JJ; Britten CM; de Jong AR; Graafland D; Melief CJ; van der Burg SH; van der Marel G; Overkleeft HS; Filippov DV; Ossendorp F
    Mol Immunol; 2009 Mar; 46(6):1084-91. PubMed ID: 19027958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lipid-based self-adjuvanting vaccines.
    Brown LE; Jackson DC
    Curr Drug Deliv; 2005 Oct; 2(4):383-93. PubMed ID: 16305441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Synthesis of a highly pure lipid core peptide based self-adjuvanting triepitopic group A streptococcal vaccine, and subsequent immunological evaluation.
    Moyle PM; Olive C; Ho MF; Good MF; Toth I
    J Med Chem; 2006 Oct; 49(21):6364-70. PubMed ID: 17034142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Toll-like receptor 2 agonists exacerbate accelerated nephrotoxic nephritis.
    Brown HJ; Sacks SH; Robson MG
    J Am Soc Nephrol; 2006 Jul; 17(7):1931-9. PubMed ID: 16738018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TLR4 and MyD88 control protection and pulmonary granulocytic recruitment in a murine intranasal RSV immunization and challenge model.
    Cyr SL; Angers I; Guillot L; Stoica-Popescu I; Lussier M; Qureshi S; Burt DS; Ward BJ
    Vaccine; 2009 Jan; 27(3):421-30. PubMed ID: 19013492
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Self-adjuvanting multicomponent cancer vaccine candidates combining per-glycosylated MUC1 glycopeptides and the Toll-like receptor 2 agonist Pam3CysSer.
    Wilkinson BL; Day S; Malins LR; Apostolopoulos V; Payne RJ
    Angew Chem Int Ed Engl; 2011 Feb; 50(7):1635-9. PubMed ID: 21308921
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipidation of intact proteins produces highly immunogenic vaccine candidates.
    Zeng W; Eriksson EM; Lew A; Jackson DC
    Mol Immunol; 2011 Jan; 48(4):490-6. PubMed ID: 21056473
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis of thiol-reactive lipopeptide adjuvants. Incorporation into liposomes and study of their mitogenic effect on mouse splenocytes.
    Roth A; Espuelas S; Thumann C; Frisch B; Schuber F
    Bioconjug Chem; 2004; 15(3):541-53. PubMed ID: 15149182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of Toll-like receptors 2 and 4 on reactive oxygen species and nitric oxide production by macrophage cells stimulated with root canal pathogens.
    Marcato LG; Ferlini AP; Bonfim RC; Ramos-Jorge ML; Ropert C; Afonso LF; Vieira LQ; Sobrinho AP
    Oral Microbiol Immunol; 2008 Oct; 23(5):353-9. PubMed ID: 18793356
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential activation of dendritic cells by Toll-like receptor agonists isolated from the Gram-positive vaccine vector Streptococcus gordonii.
    Mayer ML; Phillips CM; Townsend RA; Halperin SA; Lee SF
    Scand J Immunol; 2009 Apr; 69(4):351-6. PubMed ID: 19284500
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.